ÂÜÀòÂÒÂ×

Ilona Holcomb is the current Director of Bioscience at ImpriMed. Ilona has also been the Group Lead at Takara Bio USA, Inc., and the Director of Research and Development at Dahlia Biosciences. Dr. Holcomb's previous experience also includes being a Senior Scientist at Fluidigm Corporation and a Postdoctoral Fellow at Stanford University and the Fred Hutchinson Cancer Research Center. Dr. Holcomb completed their Doctoral Thesis at the University of Washington and was a Research Assistant at Genentech prior to their current position.

Ilona Holcomb completed a postdoctoral fellowship in bio-oncology at Stanford University, followed by a Doctor of Philosophy in molecular biotechnology at the University of Washington. Ilona then earned a Bachelor of Science in genetics from the University of California, Davis.

They are on a team with Raghavendra Pudupakam - Lead Research Scientist, Mary Ocnean - VP, Commercial Operations, and Stanley Park - Business Operations Manager. Ilona Holcomb reports to Sungwon Lim, Co-Founder & CEO.